Herranz Amo F, Verdú Tartajo F, Díez Cordero J M, Bueno Chomón G, Leal Hernández F, Bielsa Carrillo A
Servicio de Urología, Hospital General Universitario Gregorio Marañón, Madrid.
Actas Urol Esp. 1999 Mar;23(3):214-8.
To evaluate the incidence and characteristics of tumours in the upper endothelium (TUE) that develop in patients with transitional carcinoma of the bladder treated with radical cystectomy.
Between 1986 and 1996, 160 evaluable patients who underwent cystectomy due to transitional cancer of the bladder were reviewed and found to be infiltrant in 96% cases. Follow-up either until death or to the date of the study, was carried out with intravenous urography (IVU) in the first 6 months with additional urographies at least every two years.
Five (3.1%) patients showed progress of the upper endothelium tumour, which was multifocal in 3 patients and infiltrant also in 3. No association was seen in these patients with in situ carcinoma of the bladder, or urethral invasion by the primary tumour: only one patient had tumour involvement of end ureters. After three months from diagnosis, tumour-related mortality was 50%. Incidence of upper endothelium tumours in patients with infiltrant tumour of the bladder was lower (1.9%) than in patients with surface tumour of the bladder (16.6%).
Based on data from our series, the incidence of TUE was 3.1% with a mean time interval between cystectomy and TUE diagnosis of 25.4 months. IVU was diagnostic only in 40% cases. No risk factors were identified in our patients, and mortality due to advanced stage of TUE at three months was 50%. The high percentage of patients with advanced TUE in our series warrants the addition of an annual IVU in the follow-up of these patients.
评估接受根治性膀胱切除术治疗的膀胱移行癌患者中发生的上尿路肿瘤(TUE)的发生率及特征。
回顾1986年至1996年间因膀胱移行癌接受膀胱切除术的160例可评估患者,发现96%的病例为浸润性。随访至死亡或研究日期,最初6个月采用静脉肾盂造影(IVU),之后至少每两年进行一次额外的肾盂造影。
5例(3.1%)患者出现上尿路肿瘤进展,其中3例为多灶性,3例也为浸润性。这些患者中未发现与膀胱原位癌或原发肿瘤尿道侵犯相关:仅1例患者输尿管末端有肿瘤累及。诊断后三个月,肿瘤相关死亡率为50%。膀胱浸润性肿瘤患者的上尿路肿瘤发生率(1.9%)低于膀胱表浅肿瘤患者(16.6%)。
根据我们系列研究的数据,TUE的发生率为3.1%,膀胱切除术与TUE诊断之间的平均时间间隔为2年5.4个月。IVU仅在40%的病例中具有诊断价值。我们的患者中未发现危险因素,TUE晚期三个月时的死亡率为50%。我们系列研究中TUE晚期患者的高比例表明,在这些患者的随访中应增加每年一次的IVU检查。